How a new Action Plan is putting the Baltics on the biotech map
Combining cutting-edge science with agile policy, Lithuania, Latvia and Estonia are coming together to create the Baltic Biotech Hub. DDW’s Diana… Read More
Combining cutting-edge science with agile policy, Lithuania, Latvia and Estonia are coming together to create the Baltic Biotech Hub. DDW’s Diana… Read More
Advances in artificial intelligence and synthetic biology are driving a new frontier in genomic research. Megan Thomas explores what the future of genomics will look like. New technologies for the future In a Eureka! podcast interview with McKinsey, Howard Jacob, Vice President of Genomics Research… Read More
Megan Thomas provides overview of the global market for genomics, covering its rapid reshaping of drug discovery and development to offer faster, more precise, and cost-effective pathways to new therapies while driving global collaboration and innovation. Past to present As far back as 2000, academic experts… Read More
Regulatory reform and investment in innovation have supercharged China’s biopharma sector, but will ongoing trade wars with the US pose a risk to growth? By Diana Turner. China’s role in the global biopharma sector has grown significantly in recent years. It is the world’s largest supplier of active… Read More
With uncertainty across the global financial markets and research community, is it Europe’s time to take the lead on biotech? Diana Turner reports. While biotech has so far been dominated by the US, since the inauguration of Donald Trump in January 2025, there has been considerable uncertainty, with significant… Read More
A new report has spotlighted how Switzerland has become one of the world’s most advanced Deep Tech ecosystems, led in part by the rise in the number of techbio start-ups in the country. The Swiss Deep Tech Report 2025, a Deep Tech Nation Switzerland initiative, was curated… Read More
Since the inauguration of President Trump in January, the United States has been constantly in the international news, but which US biotech companies are making headlines? Diana Spencer highlights five innovators. According to Cervicorn Consulting, the US biotechnology market size could reach around $1,470.82 billion by 20331 – though it… Read More
In less than a decade GLP-1 receptor agonists have transformed the treatment of obesity and made Novo Nordisk Europe’s most valuable company. Diana Spencer explores the current impact and potential future for these drugs. Originally designed in Scandinavia as a maintenance therapy for type 2 diabetes, GLP-1 receptor agonists are… Read More
DDW’s Diana Spencer explores some of North America’s most important life science hubs and finds out the benefits of each unique ecosystem. The United States dominates the biotech sector in North America and globally, with an estimated value share of nearly 59% in 20211. According to… Read More
The future is looking rosy for the biotechnology sector. Diana Spencer takes a world-tour of some of the key centres of innovation. According to data analysts Precedence Research, the global biotechnology market was estimated at $1.38 trillion in 2023 and is expected to be worth around $4.25 trillion by… Read More
DDW’s Diana Spencer takes a closer look into why Switzerland is such a life sciences powerhouse and how Swiss researchers are advancing new technology and tackling modern health challenges. OECD data places Switzerland second in the world for biotechnology R&D intensity1, and in 2021, the country… Read More
DDW’s Diana Spencer takes a closer look into why Switzerland is such a life sciences powerhouse and how Swiss researchers are advancing new technology and tackling modern health challenges. OECD data places Switzerland second in the world for biotechnology R&D intensity1, and in 2021, the country… Read More
Thanks to a prestigious academic legacy, Europe has long been a dominant region for life sciences. In this article, DDW’s Diana Spencer highlights several prominent hotspots that are taking the lead on advancing European drug discovery and development. Europe is traditionally a life sciences powerhouse, with a strong tradition in… Read More
Hailed as a revolution in the treatment of many diseases, cell and gene therapy (CGT) is the fastest growing area of therapeutics. 2023 was a record year for CGTs, with seven new CGTs approved by the US Food and Drug Administration (FDA) across a variety of different… Read More
With government support and strong academic institutions, does Singapore have what it takes to become a global centre for life sciences? DDW’s Diana Spencer explores how the country is turning pioneering science into a successful biotech industry. Thanks to significant investment by the government into research… Read More
The drug discovery informatics market is predicted to grow from $3.77 billion in 2024 to $6.06 billion in 2028 at a compound annual growth rate (CAGR) of 12.6%, according to analysts ResearchAndMarkets.com. The recent growth in the market is attributed to advancements in genomics and proteomics,… Read More